肾移植术后高尿酸血症的危险因素及管理
Risk factors and management of hyperuricemia after renal transplantation.
作者信息
Zi Xiaoyu, Zhang Xi, Hao Chuan, Wang Zhenxing
机构信息
Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Department of Urology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
出版信息
Front Surg. 2023 Jan 6;9:956213. doi: 10.3389/fsurg.2022.956213. eCollection 2022.
Abstract
Hyperuricemia (HUA) is a common complication after renal transplantation. Currently, there is no uniform consensus on factors which increase the risk for and treatment of HUA in renal transplant recipients. The purpose of this review is to summarize current and proposed risk factors and strategies to manage HUA after renal transplantation in order to assist renal function protection and prolong graft survival time.
摘要
高尿酸血症（HUA）是肾移植术后常见的并发症。目前，对于肾移植受者中增加HUA风险的因素及治疗方法尚无统一共识。本综述的目的是总结肾移植术后HUA的当前及潜在风险因素和管理策略，以帮助保护肾功能并延长移植物存活时间。
相似文献
1
Risk factors and management of hyperuricemia after renal transplantation.肾移植术后高尿酸血症的危险因素及管理
Front Surg. 2023 Jan 6;9:956213. doi: 10.3389/fsurg.2022.956213. eCollection 2022.
2
New insight in the immune mechanisms in hyperuricemia after renal transplantation: a narrative review.肾移植后高尿酸血症免疫机制的新见解：叙述性综述。
Eur Rev Med Pharmacol Sci. 2022 Jul;26(14):4969-4978. doi: 10.26355/eurrev_202207_29282.
3
Uric acid and transplantation.尿酸与移植
Semin Nephrol. 2005 Jan;25(1):50-5. doi: 10.1016/j.semnephrol.2004.09.008.
4
Uric acid and transplantation.尿酸与移植。
Semin Nephrol. 2011 Sep;31(5):466-71. doi: 10.1016/j.semnephrol.2011.08.012.
5
Risk Factors of Hyperuricemia After Renal Transplantation and Its Long-term Effects on Graft Functions.肾移植术后高尿酸血症的危险因素及其对移植肾功能的长期影响。
Transplant Proc. 2017 Apr;49(3):505-508. doi: 10.1016/j.transproceed.2017.01.006.
6
Is uric acid a predictive factor for graft dysfunction in renal transplant recipients?尿酸是肾移植受者移植肾功能障碍的预测因素吗？
Transplant Proc. 2007 May;39(4):1023-6. doi: 10.1016/j.transproceed.2007.03.028.
7
Hyperuricemia in pediatric renal transplant recipients.小儿肾移植受者的高尿酸血症
Exp Clin Transplant. 2013 Dec;11(6):489-93. doi: 10.6002/ect.2013.0012.
8
Phloretin ameliorates hyperuricemia-induced chronic renal dysfunction through inhibiting NLRP3 inflammasome and uric acid reabsorption.根皮苷通过抑制 NLRP3 炎性小体和尿酸重吸收改善高尿酸血症诱导的慢性肾功能障碍。
Phytomedicine. 2020 Jan;66:153111. doi: 10.1016/j.phymed.2019.153111. Epub 2019 Oct 16.
9
Urate Transporter URAT1 in Hyperuricemia: New Insights from Hyperuricemic Models.高尿酸血症中的尿酸转运体URAT1：来自高尿酸血症模型的新见解
Ann Clin Lab Sci. 2019 Nov;49(6):756-762.
10
Clinical classification of hyperuricemia in patients with chronic kidney disease.慢性肾脏病患者高尿酸血症的临床分类。
Int Urol Nephrol. 2021 Aug;53(8):1665-1674. doi: 10.1007/s11255-020-02754-x. Epub 2021 Jan 2.
引用本文的文献
1
Major adverse cardiovascular events and hyperuricemia as an effect-modifying factor in kidney transplant recipients.主要不良心血管事件及高尿酸血症作为肾移植受者的效应修饰因素
World J Transplant. 2025 Sep 18;15(3):102287. doi: 10.5500/wjt.v15.i3.102287.
2
Monosodium Urate Crystal Depletion and Bone Erosion Response in Kidney Transplant Recipients With Uncontrolled Gout Treated With Pegloticase: PROTECT Serial Dual-Energy Computed Tomography Findings.聚乙二醇化尿酸酶治疗未控制痛风的肾移植受者的尿酸钠晶体清除及骨侵蚀反应：PROTECT系列双能计算机断层扫描结果
Transplant Direct. 2025 May 12;11(6):e1803. doi: 10.1097/TXD.0000000000001803. eCollection 2025 Jun.
3
Quality of life improvements and clinical assessments in kidney transplant recipients undergoing pegloticase treatment for uncontrolled gout: findings of the phase 4 PROTECT clinical trial.接受培戈洛酶治疗的痛风控制不佳的肾移植受者的生活质量改善及临床评估：4期PROTECT临床试验结果
Front Immunol. 2025 Mar 13;16:1516146. doi: 10.3389/fimmu.2025.1516146. eCollection 2025.
本文引用的文献
1
Urate-lowering therapy for patients with gout on hemodialysis.降尿酸治疗血液透析患者的痛风。
Int J Rheum Dis. 2022 Jul;25(7):769-774. doi: 10.1111/1756-185X.14334. Epub 2022 May 16.
2
Research progress on related mechanisms of uric acid activating NLRP3 inflammasome in chronic kidney disease.尿酸激活 NLRP3 炎性小体在慢性肾脏病中相关机制的研究进展。
Ren Fail. 2022 Dec;44(1):615-624. doi: 10.1080/0886022X.2022.2036620.
3
Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout.别嘌醇与苯溴马隆治疗痛风患者的心血管风险比较。
Eur Heart J. 2021 Nov 21;42(44):4578-4588. doi: 10.1093/eurheartj/ehab619.
4
Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease.高尿酸血症的病理生理学及治疗的分子生物学和临床认识及其与代谢综合征、心血管疾病和慢性肾脏病的关系。
Int J Mol Sci. 2021 Aug 26;22(17):9221. doi: 10.3390/ijms22179221.
5
Can uric acid blood levels in renal transplant recipients predict allograft outcome?肾移植受者血尿酸水平能否预测移植物预后？
Ren Fail. 2021 Dec;43(1):1240-1249. doi: 10.1080/0886022X.2021.1969246.
6
Association between Lipid Profiles and Serum Urate: A Cross-Sectional Study in Southwestern China.血脂谱与血清尿酸之间的关联：中国西南部的一项横断面研究。
Int J Endocrinol. 2021 Jul 8;2021:2741131. doi: 10.1155/2021/2741131. eCollection 2021.
7
Fucoidan from Inhibits Expression of GLUT9 and URAT1 via PI3K/Akt, JNK and NF-κB Pathways in Uric Acid-Exposed HK-2 Cells.褐藻糖胶通过 PI3K/Akt、JNK 和 NF-κB 通路抑制尿酸暴露的 HK-2 细胞中 GLUT9 和 URAT1 的表达。
Mar Drugs. 2021 Apr 23;19(5):238. doi: 10.3390/md19050238.
8
Azathioprine-induced severe anemia potentiated by the concurrent use of allopurinol.硫唑嘌呤诱发的严重贫血因同时使用别嘌醇而加重。
CMAJ. 2021 Jan 18;193(3):E94-E97. doi: 10.1503/cmaj.201022.
9
Reduced renal function may explain the higher prevalence of hyperuricemia in older people.肾功能下降可能解释了老年人高尿酸血症患病率较高的原因。
Sci Rep. 2021 Jan 14;11(1):1302. doi: 10.1038/s41598-020-80250-z.
10
Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update.钠-葡萄糖共转运蛋白 1 和 2 抑制剂对 2 型糖尿病患者心血管和肾脏结局的影响：一项荟萃分析更新。
Am Heart J. 2021 Mar;233:86-91. doi: 10.1016/j.ahj.2020.12.007. Epub 2020 Dec 29.
Zotero 插件